These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 31897316)
1. Determination of Pathogenicity of Brown A; Zamanpoor M; Love DR; Prosser DO Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e324-e334. PubMed ID: 31897316 [TBL] [Abstract][Full Text] [Related]
2. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684 [TBL] [Abstract][Full Text] [Related]
3. Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel. Parsons MT; de la Hoya M; Richardson ME; Tudini E; Anderson M; Berkofsky-Fessler W; Caputo SM; Chan RC; Cline MS; Feng BJ; Fortuno C; Gomez-Garcia E; Hadler J; Hiraki S; Holdren M; Houdayer C; Hruska K; James P; Karam R; Leong HS; Martins A; Mensenkamp AR; Monteiro AN; Nathan V; O'Connor R; Pedersen IS; Pesaran T; Radice P; Schmidt G; Southey M; Tavtigian S; Thompson BA; Toland AE; Turnbull C; Vogel MJ; Weyandt J; Wiggins GAR; Zec L; Couch FJ; Walker LC; Vreeswijk MPG; Goldgar DE; Spurdle AB Am J Hum Genet; 2024 Sep; 111(9):2044-2058. PubMed ID: 39142283 [TBL] [Abstract][Full Text] [Related]
4. Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay. Hu C; Susswein LR; Roberts ME; Yang H; Marshall ML; Hiraki S; Berkofsky-Fessler W; Gupta S; Shen W; Dunn CA; Huang H; Na J; Domchek SM; Yadav S; Monteiro ANA; Polley EC; Hart SN; Hruska KS; Couch FJ Clin Cancer Res; 2022 Sep; 28(17):3742-3751. PubMed ID: 35736817 [TBL] [Abstract][Full Text] [Related]
5. MARGINAL: An Automatic Classification of Variants in Karalidou V; Kalfakakou D; Papathanasiou A; Fostira F; Matsopoulos GK Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358902 [TBL] [Abstract][Full Text] [Related]
6. Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide. Hirotsu Y; Schmidt-Edelkraut U; Nakagomi H; Sakamoto I; Hartenfeller M; Narang R; Soldatos TG; Kaduthanam S; Wang X; Hettich S; Brock S; Jackson DB; Omata M Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486089 [No Abstract] [Full Text] [Related]
7. Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections. Ponińska JK; Bilińska ZT; Truszkowska G; Michalak E; Podgórska A; Stępień-Wojno M; Chmielewski P; Lutyńska A; Płoski R J Transl Med; 2022 Jan; 20(1):42. PubMed ID: 35078481 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for Innella G; Ferrari S; Miccoli S; Luppi E; Fortuno C; Parsons MT; Spurdle AB; Turchetti D J Med Genet; 2024 Apr; 61(5):483-489. PubMed ID: 38160042 [TBL] [Abstract][Full Text] [Related]
9. Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants. Brandt T; Sack LM; Arjona D; Tan D; Mei H; Cui H; Gao H; Bean LJH; Ankala A; Del Gaudio D; Knight Johnson A; Vincent LM; Reavey C; Lai A; Richard G; Meck JM Genet Med; 2020 Feb; 22(2):336-344. PubMed ID: 31534211 [TBL] [Abstract][Full Text] [Related]
10. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines. So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392 [TBL] [Abstract][Full Text] [Related]
11. Variant classification changes over time in BRCA1 and BRCA2. Mighton C; Charames GS; Wang M; Zakoor KR; Wong A; Shickh S; Watkins N; Lebo MS; Bombard Y; Lerner-Ellis J Genet Med; 2019 Oct; 21(10):2248-2254. PubMed ID: 30971832 [TBL] [Abstract][Full Text] [Related]
12. Reclassification of Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel pathogenic variant in Laraqui A; Cavaillé M; Uhrhammer N; ElBiad O; Bidet Y; El Rhaffouli H; El Anaz H; Rahali DM; Kouach J; Guelzim K; Badaoui B; AlBouzidi A; Oukabli M; Tanz R; Sbitti Y; Ichou M; Ennibi K; Sekhsokh Y; Bignon YJ J Genomics; 2021; 9():43-54. PubMed ID: 34646395 [TBL] [Abstract][Full Text] [Related]
14. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Richards S; Aziz N; Bale S; Bick D; Das S; Gastier-Foster J; Grody WW; Hegde M; Lyon E; Spector E; Voelkerding K; Rehm HL; Genet Med; 2015 May; 17(5):405-24. PubMed ID: 25741868 [TBL] [Abstract][Full Text] [Related]
15. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants. Lee K; Krempely K; Roberts ME; Anderson MJ; Carneiro F; Chao E; Dixon K; Figueiredo J; Ghosh R; Huntsman D; Kaurah P; Kesserwan C; Landrith T; Li S; Mensenkamp AR; Oliveira C; Pardo C; Pesaran T; Richardson M; Slavin TP; Spurdle AB; Trapp M; Witkowski L; Yi CS; Zhang L; Plon SE; Schrader KA; Karam R Hum Mutat; 2018 Nov; 39(11):1553-1568. PubMed ID: 30311375 [TBL] [Abstract][Full Text] [Related]
16. Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Tavtigian SV; Greenblatt MS; Harrison SM; Nussbaum RL; Prabhu SA; Boucher KM; Biesecker LG; Genet Med; 2018 Sep; 20(9):1054-1060. PubMed ID: 29300386 [TBL] [Abstract][Full Text] [Related]
17. Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients. Lattimore V; Parsons MT; Spurdle AB; Pearson J; Lehnert K; Sullivan J; Lintott C; Bawden S; Morrin H; Robinson B; Walker L Breast Cancer Res Treat; 2021 Feb; 185(3):583-590. PubMed ID: 33113089 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls. Park JS; Nam EJ; Park HS; Han JW; Lee JY; Kim J; Kim TI; Lee ST Cancer Res Treat; 2017 Oct; 49(4):1012-1021. PubMed ID: 28111427 [TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 truncating mutations and variants of unknown significance in Egyptian female breast cancer patients. AbdelHamid SG; Zekri AN; AbdelAziz HM; El-Mesallamy HO Clin Chim Acta; 2021 Jan; 512():66-73. PubMed ID: 33278427 [TBL] [Abstract][Full Text] [Related]
20. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance. Lyra PCM; Nepomuceno TC; de Souza MLM; Machado GF; Veloso MF; Henriques TB; Dos Santos DZ; Ribeiro IG; Ribeiro RS; Rangel LBA; Richardson M; Iversen ES; Goldgar D; Couch FJ; Carvalho MA; Monteiro ANA Genet Med; 2021 Feb; 23(2):306-315. PubMed ID: 33087888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]